# The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan Treatment

> **NCT04270344** · — · UNKNOWN · sponsor: **JW Pharmaceutical** · enrollment: 905 (estimated)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Pitavastatin 4mg

## Key facts

- **NCT ID:** NCT04270344
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 905 (ESTIMATED)
- **Last updated:** 2021-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04270344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04270344, "The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan Treatment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04270344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*